AAA March 2015 – Page 4

Rigontec extends series A to $15.6m

Germany-based biopharmaceutical company Rigontec extended a series A round featuring Boehringer Ingelheim Venture Fund, the investment arm of pharmaceutical company Boehringer Ingelheim to almost €14.3m ($15.6m) today. Venture capital firms Forbion Capital Partners and Sunstone Capital provided the €4.8m for the second tranche. Rigontec raised €9.45m in October 2014 from backers including Boehringer Ingelheim, German… Continue reading Rigontec extends series A to $15.6m